• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Nuvo Pharmaceuticals Shares Q3 Financial Results

    Bryan Mc Govern
    Nov. 02, 2017 09:34AM PST
    Pharmaceutical Investing

    Nuvo Pharmaceuticals announced its financial and operational results for their third quarter of the year.

    Nuvo Pharmaceuticals (TSX:NRI) announced its financial and operational results for their third quarter of the year.
    As quoted in the press release:

    Third Quarter 2017 and Business Update

    • U.S. prescriptions of Pennsaid 2% were 108,000 in the third quarter of 2017 compared to 103,000 prescriptions in the third quarter of 2016 according to IMS Health.  For the first nine months of 2017, U.S. prescriptions of Pennsaid 2% were 324,000 compared to 338,000 for the first nine months of 2016.
    • In August 2017, the Company announced it had secured a $6.0 million operating revolving credit facility (Facility) with Royal Bank of Canada (RBC).  The Facility is a standby Facility that can be drawn by Nuvo for working capital requirements and general corporate purposes.  Drawings are limited to a percentage of the Company’s then outstanding accounts receivable and inventory.  The Company has not drawn any amount of the Facility.

    Click here to read the full press release.

    Source: www.newswire.ca

    pharmaceutical investingbusiness updatenuvo pharmaceuticalscanadapennsaid 2%
    The Conversation (0)

    Go Deeper

    AI Powered
    Medical pills branded with Canadian flag.

    Canadian Pharma Stocks: 5 Biggest Companies

    Test tubes.

    Amgen, Merck and Pfizer Release Latest Quarterly Earnings, Share 2025 Plans

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Cardiol Therapeutics

    CRDL:CA

    Invion Limited

    IVX:AU

    Principal Technologies

    PTEC:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES